Literature DB >> 8362945

Atypical pelvic inflammatory disease: can we identify clinical predictors?

W Cates1, M R Joesoef, M B Goldman.   

Abstract

OBJECTIVE: We used data from a large multicenter case-control study of tubal infertility to analyze further the relationship among demographic variables, behavioral measures, history of previous sexually transmitted diseases, and past contraceptive practices, for women with and without a history of pelvic inflammatory disease. STUDY
DESIGN: We identified 283 white women with tubal infertility who requested care at seven participating institutions. Of these women, 238 (84%) did not have a history of pelvic inflammatory disease ("atypical pelvic inflammatory disease") whereas 45 reported a history of pelvic inflammatory disease ("overt pelvic inflammatory disease"). We compared these groups with 1629 white women without a history of either infertility or pelvic inflammatory disease who were delivered of their first live-born child at the same institutions as the infertile cases.
RESULTS: Women with atypical pelvic inflammatory disease were demographically more like fertile control subjects and had behavioral characteristics midway between those of the overt pelvic inflammatory disease group and the fertile group. Both oral contraceptive and diaphragm use protected against tubal infertility for women with either atypical or overt pelvic inflammatory disease. Atypical pelvic inflammatory disease was related to a history of Trichomonas infection but not to a reported history of gonorrhea, genital herpes, or other vaginitis.
CONCLUSION: Atypical pelvic inflammatory disease is probably more common than its symptomatic counterpart. Whereas this condition is associated with some characteristics of a sexually transmitted infection, clinical predictors remain elusive.

Entities:  

Mesh:

Year:  1993        PMID: 8362945     DOI: 10.1016/0002-9378(93)90085-w

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  21 in total

1.  Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations.

Authors:  T Meri; T S Jokiranta; L Suhonen; S Meri
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Prevalence and comparison of diagnostic methods for Trichomonas vaginalis infection in pregnant women in Argentina.

Authors:  Beatriz E Perazzi; Claudia I Menghi; Enrique F Coppolillo; Claudia Gatta; Martha Cora Eliseth; Ramón A de Torres; Carlos A Vay; Angela M R Famiglietti
Journal:  Korean J Parasitol       Date:  2010-03-18       Impact factor: 1.341

3.  In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis.

Authors:  E M Narcisi; W E Secor
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

4.  Cost effectiveness analysis of azithromycin and doxycycline for Chlamydia trachomatis infection in women: A Canadian perspective.

Authors:  F Marra; C A Marra; D M Patrick
Journal:  Can J Infect Dis       Date:  1997-07

Review 5.  Sexually transmitted diseases and infertility.

Authors:  Danielle G Tsevat; Harold C Wiesenfeld; Caitlin Parks; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2017-01       Impact factor: 8.661

Review 6.  Mycoplasma genitalium in Women: Current Knowledge and Research Priorities for This Recently Emerged Pathogen.

Authors:  Harold C Wiesenfeld; Lisa E Manhart
Journal:  J Infect Dis       Date:  2017-07-15       Impact factor: 5.226

Review 7.  Immunopathogenic consequences of Chlamydia trachomatis 60 kDa heat shock protein expression in the female reproductive tract.

Authors:  Iara Moreno Linhares; Steven S Witkin
Journal:  Cell Stress Chaperones       Date:  2010-02-25       Impact factor: 3.667

Review 8.  Chlamydia trachomatis in adolescents and adults. Clinical and economic implications.

Authors:  C A Marra; D M Patrick; R Reynolds; F Marra
Journal:  Pharmacoeconomics       Date:  1998-02       Impact factor: 4.981

9.  Comparison of culture and different PCR assays for detection of Trichomonas vaginalis in self collected vaginal swab specimens.

Authors:  T Crucitti; E Van Dyck; A Tehe; S Abdellati; B Vuylsteke; A Buve; M Laga
Journal:  Sex Transm Infect       Date:  2003-10       Impact factor: 3.519

10.  Community based study of sexually transmitted diseases in rural women in the highlands of Papua New Guinea: prevalence and risk factors.

Authors:  M Passey; C S Mgone; S Lupiwa; N Suve; S Tiwara; T Lupiwa; A Clegg; M P Alpers
Journal:  Sex Transm Infect       Date:  1998-04       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.